These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

138 related articles for article (PubMed ID: 38573057)

  • 1. How New Regulation of Laboratory-Developed Antimicrobial Susceptibility Tests Will Affect Infectious Diseases Clinical Practice.
    Wolfe KH; Pierce VM; Humphries RM
    Clin Infect Dis; 2024 May; 78(5):1140-1147. PubMed ID: 38573057
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Setting Antimicrobial Susceptibility Testing Breakpoints: A Primer for Pediatric Infectious Diseases Specialists on the Clinical and Laboratory Standards Institute Approach.
    Pierce VM; Mathers AJ
    J Pediatric Infect Dis Soc; 2022 Feb; 11(2):73-80. PubMed ID: 34888640
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Emerging Resistance, New Antimicrobial Agents  …  but No Tests! The Challenge of Antimicrobial Susceptibility Testing in the Current US Regulatory Landscape.
    Humphries RM; Hindler JA
    Clin Infect Dis; 2016 Jul; 63(1):83-8. PubMed ID: 27025822
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Antimicrobial susceptibility testing: An updated primer for clinicians in the era of antimicrobial resistance: Insights from the Society of Infectious Diseases Pharmacists.
    Wenzler E; Maximos M; Asempa TE; Biehle L; Schuetz AN; Hirsch EB
    Pharmacotherapy; 2023 Apr; 43(4):264-278. PubMed ID: 36825480
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Understanding and Addressing CLSI Breakpoint Revisions: a Primer for Clinical Laboratories.
    Humphries RM; Abbott AN; Hindler JA
    J Clin Microbiol; 2019 Jun; 57(6):. PubMed ID: 30971460
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Twenty-first Century Cures Act and Antimicrobial Susceptibility Testing: Clinical Implications in the Era of Multidrug Resistance.
    Humphries RM; Hindler J; Jane Ferraro M; Mathers A
    Clin Infect Dis; 2018 Sep; 67(7):1132-1138. PubMed ID: 29796616
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A survey of methods used for antimicrobial susceptibility testing in veterinary diagnostic laboratories in the United States.
    Dargatz DA; Erdman MM; Harris B
    J Vet Diagn Invest; 2017 Sep; 29(5):669-675. PubMed ID: 28599616
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Who defines resistance? The clinical and economic impact of antimicrobial susceptibility testing breakpoints.
    Jorgensen JH
    Semin Pediatr Infect Dis; 2004 Apr; 15(2):105-8. PubMed ID: 15185194
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Impact of 21st Century Cures Act on Breakpoints and Commercial Antimicrobial Susceptibility Test Systems: Progress and Pitfalls.
    Humphries RM; Ferraro MJ; Hindler JA
    J Clin Microbiol; 2018 May; 56(5):. PubMed ID: 29436415
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Updating breakpoints in the United States: a summary from the ASM Clinical Microbiology Open 2022.
    Patel JB; Alby K; Humphries R; Weinstein M; Lutgring JD; Naccache SN; Simner PJ
    J Clin Microbiol; 2023 Oct; 61(10):e0115422. PubMed ID: 37791777
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Rationale for a Neisseria gonorrhoeae Susceptible-only Interpretive Breakpoint for Azithromycin.
    Kersh EN; Allen V; Ransom E; Schmerer M; Cyr S; Workowski K; Weinstock H; Patel J; Ferraro MJ
    Clin Infect Dis; 2020 Feb; 70(5):798-804. PubMed ID: 30963175
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clinical breakpoint changes and their impact on surveillance of antimicrobial resistance in Escherichia coli causing bacteraemia.
    van der Bij AK; van Dijk K; Muilwijk J; Thijsen SF; Notermans DW; de Greeff S; van de Sande-Bruinsma N;
    Clin Microbiol Infect; 2012 Nov; 18(11):E466-72. PubMed ID: 22925456
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Systems approach to improving antimicrobial susceptibility testing in clinical laboratories in the United States.
    Counts JM; Astles JR; Tenover FC; Hindler J
    J Clin Microbiol; 2007 Jul; 45(7):2230-4. PubMed ID: 17522281
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Raising the Bar: Improving Antimicrobial Resistance Detection by Clinical Laboratories by Ensuring Use of Current Breakpoints.
    Simner PJ; Rauch CA; Martin IW; Sullivan KV; Rhoads D; Rolf R; She R; Souers RJ; Wojewoda C; Humphries RM
    Open Forum Infect Dis; 2022 Mar; 9(3):ofac007. PubMed ID: 35146049
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Rationale for revised penicillin susceptibility breakpoints versus Streptococcus pneumoniae: coping with antimicrobial susceptibility in an era of resistance.
    Weinstein MP; Klugman KP; Jones RN
    Clin Infect Dis; 2009 Jun; 48(11):1596-600. PubMed ID: 19400744
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Impact of Delays between Clinical and Laboratory Standards Institute and Food and Drug Administration Revisions of Interpretive Criteria for Carbapenem-Resistant Enterobacteriaceae.
    Bartsch SM; Huang SS; Wong KF; Slayton RB; McKinnell JA; Sahm DF; Kazmierczak K; Mueller LE; Jernigan JA; Lee BY
    J Clin Microbiol; 2016 Nov; 54(11):2757-2762. PubMed ID: 27582516
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Performance evaluation of VITEK 2 system in meropenem susceptibility testing of clinical Pseudomonas aeruginosa isolates].
    Acuner IC; Bayramoğlu G; Birinci A; Cekiç Cihan C; Bek Y; Durupınar B
    Mikrobiyol Bul; 2011 Jul; 45(3):411-21. PubMed ID: 21935774
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Role of NCCLS in antimicrobial susceptibility testing and monitoring.
    Ginocchio CC
    Am J Health Syst Pharm; 2002 Apr; 59(8 Suppl 3):S7-11. PubMed ID: 11977864
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Revision of fluoroquinolone breakpoints used for interpretation of antimicrobial susceptibility testing of canine bacterial isolates.
    Papich MG; Gunnett LA; Lubbers BV
    Am J Vet Res; 2023 Nov; 84(11):. PubMed ID: 37673214
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Harmonization of antimicrobial susceptibility testing breakpoints in Europe: implications for reporting intermediate susceptibility.
    Brown D; Macgowan A
    J Antimicrob Chemother; 2010 Feb; 65(2):183-5. PubMed ID: 19996143
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.